Nektar Therapeutics (NKTR) EBIT Growth (3y) (2013 - 2026)
Nektar Therapeutics (NKTR) EBIT Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 38.78% |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 13.47% |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -12.10% |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 79.65% |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Nektar Therapeutics | 1.76 Bn | 1.19 Bn | 3.16 Mn | 33.82% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 33.82% |
| Dec 31, 2025 | 19.21% |
| Sep 30, 2025 | 16.45% |
| Jun 30, 2025 | 38.11% |
| Mar 31, 2025 | 27.44% |
| Dec 31, 2024 | 28.61% |
| Sep 30, 2024 | 32.88% |
| Jun 30, 2024 | 23.28% |
| Mar 31, 2024 | 31.33% |
| Dec 31, 2023 | 32.86% |
| Sep 30, 2023 | 24.21% |
| Jun 30, 2023 | 13.33% |
| Mar 31, 2023 | -0.27% |
| Dec 31, 2022 | 21.78% |
| Sep 30, 2022 | 18.07% |
| Jun 30, 2022 | -11.26% |
| Mar 31, 2022 | 1.15% |
| Dec 31, 2021 | -4.03% |
| Sep 30, 2021 | -4.82% |
| Jun 30, 2021 | -28.33% |